课题基金 / 基金详情

Bisphosphonate use, oral flora, saliva, gingival crevicular fluid and bone markers in patients with jaw osteonecrosis

Bisphosphonate use, oral flora, saliva, gingival crevicular fluid and bone markers in patients with jaw osteonecrosis
颌骨坏死患者双膦酸盐的使用、口腔菌群、唾液、龈沟液和骨标志物
批准号:
nhmrc : 520172
负责人:
Dr Claudine Tsao
金额:
$8.12万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Postgraduate Scholarships
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-01-01 至 2012-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bisphosphonates are used in patients with bones that break easily due to conditions such as osteoporosis. Recent research suggests a possible association between these drugs and jaw bone breakdown called jaw osteonecrosis - a devastating condition with no current effective treatment. It is unclear why this condition affects only jaw bones. This study seeks to investigate if bacteria in the mouth, gum disease and saliva are involved in jaw osteonecrosis, which can then help to improve management.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
降低慢病毒载体转录“通读率”的研究
  • 批准号:
    81271690
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2012
  • 负责人:
    张敬之
  • 依托单位: